Google Unveiled Upgraded AI Technology That Predicts The Structure And Shape Of Molecules In The Human Body, Potentially Paving The Way For New Discoveries In Vaccine And Drug Development

With the help of artificial intelligence, machines now have the power to generate videos, write computer code, create art, hold conversations, and even help further efforts to understand the human body.
In May, Google unveiled an upgraded version of its AlphaFold software, an artificial intelligence technology that predicts the structure and shape of molecules in the human body.
A molecule’s function and behavior can be determined by its shape, so scientists have been studying the connection for years.
The AI tool can accelerate and simplify the process, saving time and labor. It can also lead to new discoveries in vaccine and drug development.
In a study published in the journal Nature, the details of AlphaFold 3, the latest update from Deepmind, which is the central artificial intelligence lab at Google, are described.
The software was first announced in 2018. Another version, AlphaFold 2, was released in 2020, and it came with a lot of improvements.
The next year, an open-source version of AlphaFold was released, along with the predicted three-dimensional shapes of almost all the proteins in the human body. In 2022, two million predicted protein structures were shared.
Scientists used the technology to learn more about the human heart and gain more knowledge about the eggs of extinct birds.
Furthermore, researchers at the University of California, San Francisco, employed the software to better understand the coronavirus and pandemics in general. Still, it had its limits.

Gorodenkoff – stock.adobe.com – illustrative purposes only, not the actual person
The newest update to the system can predict not only the structure of proteins but also the structures of DNA, RNA, and other molecules.
As a result, researchers can improve their predictions and studies of how different molecules interact, as well as pinpoint where a drug might bind to a protein.
This kind of technology will streamline the process of creating new drugs and vaccines to help fight against disease. Some researchers have been utilizing it to seek out cures for malaria and Parkinson’s disease.
According to Deniz Kavi, co-founder and chief executive of a start-up for drug discovery, the technology can “save months of experimental work and enable research that was previously impossible.” He added that it “represents tremendous promise.”
Sign up for Chip Chick’s newsletter and get stories like this delivered to your inbox.
More About:News